Spruson & Ferguson recognised in 2026 IAM Patent 1000
Spruson & Ferguson has once again been recognised in the 2026 IAM Patent 1000: The World’s Leading Patent Professionals, with rankings across the Asia-Pacific. This year our Thailand and China...
Spruson & Ferguson has once again been recognised in the 2026 IAM Patent 1000: The World’s Leading Patent Professionals, ...
Read More
China | Data exclusivity comes into effect
The National Medical Products Administration (NMPA) released the Implementation Measures for the Protection of Drug Trial Data on 15 May 2026 with immediate effect, i.e. simultaneously with the Implementing...
The National Medical Products Administration (NMPA) released the Implementation Measures for the Protection of Drug Trial Data on 15...
Read More
Extending Protection for Pharmaceuticals | Requirements in Australia, China and Singapore 
Our teams across the Asia Pacific explore how pharmaceutical innovators can extend protection for their therapeutic products through patent term extensions (PTEs) and data exclusivity in Australia, China, and Singapore. A comparison table is provided below which summarises key requirements and timing considerations for...
Our teams across the Asia Pacific explore how pharmaceutical innovators can extend protection for their therapeutic products through patent term extensions (PTEs) and data...
Read More
Australia | Navigating Best Method after NOCO
On 10 April 2026, the Full Federal Court handed down its decision in The NOCO Company v Brown and Watson(NOCO). That decision contained significant ramifications for divisional applications in...
On 10 April 2026, the Full Federal Court handed down its decision in The NOCO Company v Brown and...
Read More
IP Australia 2026 Intellectual Property Report
IP Australia has released the fourteenth edition of the 'Australian Intellectual Property Report' (the Report) which presents key movements in IP statistics and explores the links between innovation, collaboration...
IP Australia has released the fourteenth edition of the 'Australian Intellectual Property Report' (the Report) which presents key movements...
Read More
Australia | Lessons from recent interlocutory injunctions in pharmaceutical patent cases 
Is it becoming easier to obtain interlocutory injunctions in Australian pharmaceutical patent cases? We provide an overview of recent decisions in Australia’s Federal Court that shine a light on some key lessons for patent owners. Overview In...
Is it becoming easier to obtain interlocutory injunctions in Australian pharmaceutical patent cases? We provide an overview of recent decisions in Australia’s Federal Court that...
Read More